Literature DB >> 6571990

Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states.

S Avissar, G Amitai, M Sokolovsky.   

Abstract

The potent muscarinic photoaffinity reagent N-methyl-4-piperidyl p-azidobenzilate (azido-4NMPB) was used to covalently label specific muscarinic binding sites in various brain regions and in the heart. In the cortex and hippocampus, a single specifically labeled protein with an apparent molecular mass of 86,000 daltons was detected by gel electrophoresis. In the medulla pons, cerebellum, and cardiac atria, there was a 160,000-dalton band in addition to the 86,000-dalton polypeptide. Under certain conditions, alkali or hydroxylamine treatment dissociated both macromolecules into a single 40,000-dalton polypeptide. These results suggest that the muscarinic receptor exists in oligomeric forms and that a dimer and tetramer of a basic 40,000-dalton peptide may exist as interconvertible species. We propose a model to explain the biological architecture of the muscarinic receptors and suggest a possible correlation between the azido-4NMPB-labeled polypeptides and the two states of the receptor observed in agonist binding experiments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6571990      PMCID: PMC393329          DOI: 10.1073/pnas.80.1.156

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Agonist-induced increase in apparent beta-adrenergic receptor size.

Authors:  L E Limbird; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

2.  The binding of agonists to brain muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

3.  Covalent binding and hemolytic activity of complement proteins.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

4.  Agonist-specific reverse regulation of muscarinic receptors by transition metal ions and guanine nucleotides.

Authors:  D Gurwitz; M Sokolovsky
Journal:  Biochem Biophys Res Commun       Date:  1980-10-16       Impact factor: 3.575

5.  Muscarinic receptor binding in mouse brain: regulation by guanine nucleotides.

Authors:  M Sokolovsky; D Gurwitz; R Galron
Journal:  Biochem Biophys Res Commun       Date:  1980-05-30       Impact factor: 3.575

6.  A possible role of synaptic-membrane protein phosphorylation in the regulation of muscarinic acetylcholine receptors.

Authors:  R D Burgoyne
Journal:  FEBS Lett       Date:  1980-12-29       Impact factor: 4.124

7.  Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization.

Authors:  Y Kloog; Y Egozi; M Sokolovsky
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

8.  Mechanism of acetylcholine release: possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation.

Authors:  D M Michaelson; S Avissar; Y Kloog; M Sokolovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Biochemical characterization of muscarinic receptors.

Authors:  M Sokolovsky; Y Egozi; Y Kloog
Journal:  Monogr Neural Sci       Date:  1980
View more
  20 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation.

Authors:  Carine Monnier; Haijun Tu; Emmanuel Bourrier; Claire Vol; Laurent Lamarque; Eric Trinquet; Jean-Philippe Pin; Philippe Rondard
Journal:  EMBO J       Date:  2010-11-09       Impact factor: 11.598

Review 3.  Oligomerization of G protein-coupled receptors: past, present, and future.

Authors:  Paul S-H Park; Slawomir Filipek; James W Wells; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

Review 4.  Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.

Authors:  Rafael Franco
Journal:  J Neural Transm (Vienna)       Date:  2008-11-11       Impact factor: 3.575

5.  Effect of proteolytic cleavage on functional properties of muscarinic acetylcholine receptors in rat pancreatic and parotid acinar cells.

Authors:  S R Hootman; T M Picado-Leonard
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

6.  Identification of endothelin receptor subtypes in sheep choroid plexus.

Authors:  K Angelova; D Puett; P Narayan
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

7.  Functional rescue of a constitutively desensitized beta2AR through receptor dimerization.

Authors:  T E Hebert; T P Loisel; L Adam; N Ethier; S S Onge; M Bouvier
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

8.  Smoothened oligomerization/higher order clustering in lipid rafts is essential for high Hedgehog activity transduction.

Authors:  Dawei Shi; Xiangdong Lv; Zhao Zhang; Xiaofeng Yang; Zhaocai Zhou; Lei Zhang; Yun Zhao
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

9.  Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides.

Authors:  D Gurwitz; Y Kloog; M Sokolovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Purification of the muscarinic acetylcholine receptor from porcine atria.

Authors:  G L Peterson; G S Herron; M Yamaki; D S Fullerton; M I Schimerlik
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.